Shu Yazaki

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2025

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 26, 2025

Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer.

Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer.

Journal: NPJ breast cancer

Published: May 22, 2025

Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis.

Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis.

Journal: EBioMedicine

Published: October 30, 2024

Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer.

Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer.

Journal: Cancer science

Published: September 28, 2024

Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer.

Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists

Published: June 24, 2024

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.

Journal: JAMA

Published: April 02, 2024

Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine.

Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine.

Journal: Breast cancer (Tokyo, Japan)

Published: March 18, 2024

Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study.

Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study.

Journal: Breast cancer : basic and clinical research

Published: January 25, 2024

Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.

Immunogenicity after vaccination of COVID-19 vaccines in patients with cancer: a prospective, single center, observational study.

Journal: International journal of clinical oncology

Published: November 12, 2023

Trop-2 expression and the tumor immune microenvironment in cervical cancer.

Trop-2 expression and the tumor immune microenvironment in cervical cancer.

Journal: Gynecologic oncology

Published: October 24, 2023

Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer.

Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer.

Journal: Virchows Archiv : an international journal of pathology

Published: May 19, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026